These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8097561)

  • 1. Primary prophylaxis against Pneumocystis carinii pneumonia.
    Tarabey R
    N Engl J Med; 1993 May; 328(20):1499. PubMed ID: 8097561
    [No Abstract]   [Full Text] [Related]  

  • 2. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
    JAMA; 1991 Apr; 265(13):1637-40, 1643-4. PubMed ID: 1672167
    [No Abstract]   [Full Text] [Related]  

  • 3. From the Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV.
    JAMA; 1992 May; 267(17):2294-6, 2298-9. PubMed ID: 1348788
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
    MMWR Recomm Rep; 1991 Mar; 40(RR-2):1-13. PubMed ID: 1672036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Kovacs JA; Masur H
    Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting risk of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.
    Rutstein RM
    Am J Dis Child; 1991 Aug; 145(8):922-4. PubMed ID: 1677526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia.
    Coker RJ; Nieman R; McBride M; Mitchell DM; Harris JR; Weber JN
    Lancet; 1992 Oct; 340(8827):1099. PubMed ID: 1357487
    [No Abstract]   [Full Text] [Related]  

  • 8. [When and how should primary prevention against Pneumocystis carinii pneumonia be carried out in HIV infection?].
    Eeftinck Schattenkerk JK; Hoepelman IM
    Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1579-81. PubMed ID: 1975648
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus.
    MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
    Kletzel M; Beck S; Elser J; Shock N; Burks W
    Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHS issues guidelines for P. carinii pneumonia prophylaxis.
    Am Fam Physician; 1989 Sep; 40(3):292, 294, 297. PubMed ID: 2532863
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA
    Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1.
    Rigaud M; Pollack H; Leibovitz E; Kim M; Persaud D; Kaul A; Lawrence R; John DD; Borkowsky W; Krasinski K
    J Pediatr; 1994 Sep; 125(3):476-80. PubMed ID: 7915306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of cotrimoxazole as prophylaxis against Pneumocystis carinii pneumonia.
    Evans JK; McOwan A; Hillman RJ; Forster GE
    Genitourin Med; 1995 Apr; 71(2):120-2. PubMed ID: 7744401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.